XML 51 R31.htm IDEA: XBRL DOCUMENT
v3.21.2

STOCK OPTIONS AND WARRANTS (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2021 | Dec. 31, 2020
STOCK OPTIONS AND WARRANTS |  |
Schedule of stock option activity |
|  | September 30, 2021 |
Risk-free interest rates |  | 0.74%-0.84% |
Expected life (in years) |  |  | 5.00 |
Expected volatility |  | 295%-325% |
Dividend yield |  |  | 0.00 | %
|  | Options Outstanding |  |  | Weighted Average Exercise Price |
Outstanding at December 31, 2018 |  |  | 30 |  |  | $ | 10,924.00 |
Assumed in recapitalization |  |  | 35,894 |  |  |  | 11.88 |
Cancelled in recapitalization |  |  | (30 | ) |  |  | 10,924.00 |
Granted post-recapitalization |  |  | 313,499 |  |  |  | 10.93 |
Granted |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |
Expired or cancelled |  |  | (25 | ) |  |  | 70.00 |
Outstanding at December 31, 2019 |  |  | 349,368 |  |  |  | 11.03 |
Granted |  |  | 326,936 |  |  |  | 5.60 |
Exercised |  |  | - |  |  |  | - |
Expired or cancelled |  |  | - |  |  |  | - |
Outstanding at December 31, 2020 |  |  | 676,304 |  |  | $ | 8.40 |
Exercisable at December 31, 2020 |  |  | 381,293 |  |  | $ | 10.68 |
Schedule of fair value of stock options granted |
|  |  |  |  | Weighted |
|  |  |  |  | Average |
|  |  |  |  | Exercise |
|  | Warrants |  |  | Price per |
|  | Outstanding |  |  | Share |
Outstanding at December 31, 2019 |  |  | 470,939 |  |  |  | 4.80 |
Issued |  |  | 2,223,438 |  |  |  | 2.01 |
Cancelled pursuant to modification |  |  | (479,533 | ) |  |  | 4.80 |
Reissued pursuant to modification |  |  | 1,438,599 |  |  |  | 1.60 |
Exercised |  |  | - |  |  |  | - |
Expired or cancelled |  |  | - |  |  |  | - |
Outstanding at December 31, 2020 |  |  | 3,653,443 |  |  |  | 1.84 |
Issued |  |  | 6,008,237 |  |  |  | 4.18 |
Cancelled pursuant to modification |  |  | (2,457,213 | ) |  |  | 2.03 |
Exchanged for common stock |  |  | (522,108 | ) |  |  | 2.60 |
Exercised |  |  | - |  |  |  | - |
Expired or cancelled |  |  | - |  |  |  | - |
Outstanding at September 30, 2021 |  |  | 6,682,359 |  |  |  | 3.92 |
Schedule of warrants outstanding |
|  |  |  |  | Wtd. Avg. |
|  |  |  |  | Exercise |
|  | Options |  |  | Price |
Outstanding at December 31, 2019 |  |  | 349,368 |  |  | $ | 4.41 |
Granted |  |  | 326,930 |  |  |  | 2.24 |
Exercised |  |  | - |  |  |  | - |
Expired or cancelled |  |  | - |  |  |  | - |
Balance, December 31, 2020 |  |  | 676,298 |  |  |  | 3.36 |
Granted during the period |  |  | 1,765,250 |  |  |  | 4.87 |
Exercised during the period |  |  | - |  |  |  | - |
Terminated/Expired during the period |  |  | (79,158 | ) |  |  | 6.87 |
Balance, September 30, 2021 |  |  | 2,362,390 |  |  | $ | 4.61 |
Exercisable at September 30, 2021 |  |  | 497,284 |  |  | $ | 3.92 |
|  | Warrants Outstanding |  |  | Weighted Average Exercise Price Per Share |
Outstanding at December 31, 2018 |  |  | 76 |  |  | $ | 2,636.00 |
Assumed in recapitalization |  |  | 900,000 |  |  |  | 2.00 |
Cancelled in recapitalization |  |  | (76 | ) |  |  | 2,636.00 |
Exchanged pursuant to recapitalization |  |  | (900,000 | ) |  |  | 2.00 |
Issued post-recapitalization |  |  | 188,376 |  |  |  | 12.00 |
Exercised |  |  | - |  |  |  | - |
Expired or cancelled |  |  | - |  |  |  | - |
Outstanding at December 31, 2019 |  |  | 188,376 |  |  |  | 12.00 |
Issued |  |  | 889,376 |  |  |  | 5.025 |
Cancelled pursuant to modification |  |  | (191,814 | ) |  |  | 12.00 |
Reissued pursuant to modification |  |  | 575,440 |  |  |  | 4.00 |
Exercised |  |  | - |  |  |  | - |
Expired or cancelled |  |  | - |  |  |  | - |
Outstanding at December 31, 2020 |  |  | 1,461,377 |  |  | $ | 4.60 |
Schedule of options outstanding and exercisable |
Exercise Price |  |  | Number Outstanding |  |  | Weighted Average Remaining Contractual Life (Years) |  |  | Weighted Average Exercise Price Exercisable |  |  | Number Exercise Price |  |  | Weighted Average |
$ | 1.00 - $2.00 |  |  |  | 35,869 |  |  |  | 2.45 |  |  | $ | 1.44 |  |  |  | 35,869 |  |  | $ | 1.44 |
$ | 2.56 |  |  |  | 190,468 |  |  |  | 2.59 |  |  | $ | 2.56 |  |  |  | 190,468 |  |  | $ | 2.56 |
$ | 3.00 - $4.00 |  |  |  | 797,419 |  |  |  | 4.47 |  |  | $ | 3.91 |  |  |  | 76,946 |  |  | $ | 3.63 |
$ | 4.00 - $5.00 |  |  |  | 943,000 |  |  |  | 4.69 |  |  | $ | 4.60 |  |  |  | 129,000 |  |  | $ | 4.62 |
$ | 6.00 - $7.00 |  |  |  | 212,934 |  |  |  | 3.55 |  |  | $ | 6.30 |  |  |  | 13,767 |  |  | $ | 6.37 |
$ | 8.00 - $9.00 |  |  |  | 180,200 |  |  |  | 4.55 |  |  | $ | 8.43 |  |  |  | 48,733 |  |  | $ | 8.41 |
$ | 16.00 |  |  |  | 2,500 |  |  |  | 1.39 |  |  | $ | 16.00 |  |  |  | 2,500 |  |  | $ | 16.00 |
|  |  |  |  | 2,362,390 |  |  |  |  |  |  |  |  |  |  |  | 497,283 |  |  |  |  |
|  |  | Options Exercisable |
|  |  | Number Outstanding |  |  | Weighted Average Remaining Contractual Life(Years) |  |  | Weighted Average Exercise Price |  |  | Number Exercisable |  |  | Weighted Average Exercise Price |
$ | 2.50-$500.00 |  |  |  | 254,530 |  |  |  | 3.35 |  |  | $ | 4.175 |  |  |  | 132,020 |  |  | $ | 4.03 |
$ | 6.25 |  |  |  | 192,936 |  |  |  | 4.16 |  |  | $ | 6.25 |  |  |  | 20,435 |  |  | $ | 6.25 |
$ 7.50-$10.00 |  |  |  | 29,870 |  |  |  | 3.30 |  |  | $ | 8.425 |  |  |  | 29,870 |  |  | $ | 8.43 |
$ | 12.00 |  |  |  | 6,000 |  |  |  | 2.49 |  |  | $ | 12.00 |  |  |  | 6,000 |  |  | $ | 12.00 |
$ | 16.00 |  |  |  | 192,968 |  |  |  | 3.29 |  |  | $ | 16.00 |  |  |  | 192,968 |  |  | $ | 16.00 |
|  |  |  |  | 676,304 |  |  |  |  |  |  |  |  |  |  |  | 381,293 |  |  |  |  |

X
- References No definition available. + Details
Name: | rcrt_ScheduleOfFairValueOfStockOptionsGrantedTableTextBlock
Namespace Prefix: | rcrt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_LineOfCreditFacilityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration